These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15971987)
1. An interview with Sheila Collins, Ph.D. Interview by Vicki Glaser. Collins S Assay Drug Dev Technol; 2005 Jun; 3(3):253-60. PubMed ID: 15971987 [No Abstract] [Full Text] [Related]
2. An interview with Michel Bouvier, Ph.D. Interview by Vicki Glaser. Bouvier M Assay Drug Dev Technol; 2006 Aug; 4(4):365-71. PubMed ID: 16945010 [No Abstract] [Full Text] [Related]
3. An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser. England P Assay Drug Dev Technol; 2004 Apr; 2(2):115-20. PubMed ID: 15165507 [No Abstract] [Full Text] [Related]
4. Nitric oxide signaling regulates mitochondrial number and function. Bossy-Wetzel E; Lipton SA Cell Death Differ; 2003 Jul; 10(7):757-60. PubMed ID: 12815458 [No Abstract] [Full Text] [Related]
5. [Alpha and beta adrenergic receptors and their specific role in the pathogenesis of obesity]. Creţeanu G; Petrovanu R Rev Med Chir Soc Med Nat Iasi; 1983; 87(4):647-52. PubMed ID: 6328613 [No Abstract] [Full Text] [Related]
6. The Heart of Diabetes. Jelly CA; Alston TA Crit Care Med; 2015 Jul; 43(7):1552-4. PubMed ID: 26079241 [No Abstract] [Full Text] [Related]
8. Beta-adrenergic receptors and regulation of energy expenditure: a family affair. Robidoux J; Martin TL; Collins S Annu Rev Pharmacol Toxicol; 2004; 44():297-323. PubMed ID: 14744248 [TBL] [Abstract][Full Text] [Related]
9. Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Lowell BB; Flier JS Annu Rev Med; 1997; 48():307-16. PubMed ID: 9046964 [TBL] [Abstract][Full Text] [Related]
10. The Glenn Foundation for Medical Research, Santa Barbara, CA: interview with Paul F. Glenn and Mark R. Collins. Interview by Vicki Glaser. Glenn PF; Collins MR Rejuvenation Res; 2007 Dec; 10(4):651-6. PubMed ID: 18158744 [No Abstract] [Full Text] [Related]
11. [Beta-3 adrenergic receptor--structure and role in obesity and metabolic disorders]. Wiejak J; Wyroba E Postepy Hig Med Dosw; 1999; 53(5):705-15. PubMed ID: 10645145 [TBL] [Abstract][Full Text] [Related]
12. An interview with Anne Hermanowski-Vosatka, M.D., Ph.D. Interview by Vicki Glaser. Hermanowski-Vosatka A Assay Drug Dev Technol; 2005 Aug; 3(4):363-6. PubMed ID: 16180990 [No Abstract] [Full Text] [Related]
13. Beta-adrenergic receptors and receptor signaling in heart failure. Post SR; Hammond HK; Insel PA Annu Rev Pharmacol Toxicol; 1999; 39():343-60. PubMed ID: 10331088 [TBL] [Abstract][Full Text] [Related]
15. An interview with Wayne Bowen, Ph.D. Interview by Vicki Glaser. Bowen W Assay Drug Dev Technol; 2006 Apr; 4(2):111-7. PubMed ID: 16712415 [No Abstract] [Full Text] [Related]
16. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure. Feldman DS; Carnes CA; Abraham WT; Bristow MR Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588 [TBL] [Abstract][Full Text] [Related]
17. An interview with Erez Raz, Ph.D. Interview by Vicki Glaser. Raz E Zebrafish; 2004; 1(1):9-11. PubMed ID: 18248200 [No Abstract] [Full Text] [Related]
18. An interview with John Postlethwait, Ph.D. Interview by Vicki Glaser. Postlethwait J Zebrafish; 2004; 1(1):3-8. PubMed ID: 18248199 [No Abstract] [Full Text] [Related]
19. An interview with David E. Harrison, Ph.D. Interview by Vicki Glaser. Harrison DE Rejuvenation Res; 2007 Sep; 10(3):417-23. PubMed ID: 17822356 [No Abstract] [Full Text] [Related]
20. [A change of signal transmission from sympathetic nervous system receptor (adrenergic receptor)]. Kawai M; Taniguchi I Nihon Rinsho; 2007 Apr; 65 Suppl 4():262-6. PubMed ID: 17508563 [No Abstract] [Full Text] [Related] [Next] [New Search]